e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Drug delivery and pharmacokinetics I
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD
P. Williamson, P. Short, B. Lipworth (Dundee, United Kingdom)
Source:
Annual Congress 2011 - Drug delivery and pharmacokinetics I
Session:
Drug delivery and pharmacokinetics I
Session type:
Thematic Poster Session
Number:
829
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Williamson, P. Short, B. Lipworth (Dundee, United Kingdom). Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD. Eur Respir J 2011; 38: Suppl. 55, 829
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children
Source: Eur Respir J 2002; 20: 630-634
Year: 2002
Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma
Source: Eur Respir J 2001; 18: 635-639
Year: 2001
Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 270s
Year: 2004
Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Optimising inhaled corticosteroid (ICS) dose using exhaled nitric oxide (eNO) measurements
Source: Eur Respir J 2003; 22: Suppl. 45, 34s
Year: 2003
Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids
Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases
Year: 2012
Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled
Source: Eur Respir J 2005; 26: Suppl. 49, 617s
Year: 2005
Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 259s
Year: 2004
Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001
Effect of salbutamol and budesonide on nitric oxide diffusion and temperature gradients in the airways
Source: Eur Respir J 2004; 24: Suppl. 48, 339s
Year: 2004
Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 429s
Year: 2004
Changes of exhaled nitric oxide during steroid treatment of childhood asthma
Source: Eur Respir J 2002; 19: 1015-1019
Year: 2002
Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide
Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases
Year: 2011
Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008
Comparison of hemodynamic effects of inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with pulmonary hypertension (PH)
Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Year: 2011
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study
Source: Eur Respir J 2014; 44: 1705-1707
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept